115 related articles for article (PubMed ID: 20134140)
1. [Treatment of disseminated intravascular coagulation].
Koyama T
Rinsho Ketsueki; 2010 Jan; 51(1):52-6. PubMed ID: 20134140
[No Abstract] [Full Text] [Related]
2. [Recent therapeutic strategy for disseminated intravascular coagulation].
Wada H; Matsumoto T; Yamashita Y
Rinsho Ketsueki; 2014 Jan; 55(1):75-82. PubMed ID: 24492040
[No Abstract] [Full Text] [Related]
3. [Anticoagulant].
Mitome J; Yamamoto H
Nihon Rinsho; 2004 May; 62 Suppl 5():368-73. PubMed ID: 15197947
[No Abstract] [Full Text] [Related]
4. The effects of danaparoid, dalteparin and heparin on tissue factor-induced experimental disseminated intravascular coagulation and bleeding time in the rat.
Miyake Y; Yokota K; Fujishima Y; Sukamoto T
Blood Coagul Fibrinolysis; 2001 Jul; 12(5):349-57. PubMed ID: 11505077
[TBL] [Abstract][Full Text] [Related]
5. [The first, second and third generations of treatments for disseminated intravascular coagulation (DIC)].
Wada H; Takemitsu S
Rinsho Byori; 2011 Feb; Suppl 147():131-5. PubMed ID: 21761761
[No Abstract] [Full Text] [Related]
6. Successful use of heparinoids in a pregnancy complicated by allergy to heparin.
Taylor AA
BJOG; 2001 Sep; 108(9):1011-2. PubMed ID: 11563455
[No Abstract] [Full Text] [Related]
7. Effect of combined therapy of danaparoid sodium and tranexamic acid on chronic disseminated intravascular coagulation associated with abdominal aortic aneurysm.
Ontachi Y; Asakura H; Arahata M; Kadohira Y; Maekawa M; Hayashi T; Yamazaki M; Morishita E; Saito M; Minami S; Nakao S
Circ J; 2005 Sep; 69(9):1150-3. PubMed ID: 16127203
[TBL] [Abstract][Full Text] [Related]
8. [Drug-induced disseminated intravascular coagulation (DIC)].
Koyama T
Nihon Rinsho; 2007 Oct; 65 Suppl 8():493-6. PubMed ID: 18074589
[No Abstract] [Full Text] [Related]
9. Pharmacokinetics of danaparoid sodium, dalteparin sodium and heparin determined by inhibitory effect on the activated coagulation factor X activity after single intravenous administration in rabbits.
Ishida M; Nakada Y; Horiuchi M; Sakamoto F
Arzneimittelforschung; 1998 Aug; 48(8):818-21. PubMed ID: 9748709
[TBL] [Abstract][Full Text] [Related]
10. Alternative anticoagulation management strategies for the patient with heparin-induced thrombocytopenia undergoing cardiac surgery.
Murphy GS; Marymont JH
J Cardiothorac Vasc Anesth; 2007 Feb; 21(1):113-26. PubMed ID: 17289495
[No Abstract] [Full Text] [Related]
11. Delayed-type hypersensitivity to subcutaneous heparin with tolerance of i.v. administration.
Liew G; Campbell C; Thursby P
ANZ J Surg; 2004 Nov; 74(11):1020-1. PubMed ID: 15550103
[No Abstract] [Full Text] [Related]
12. Aprotinin and organon 10172: a successful combination for coronary artery bypass surgery complicated by heparin-induced thrombocytopenia.
Alvarez MJ; Mezzatesta PJ
Aust N Z J Surg; 2000 Nov; 70(11):819-21. PubMed ID: 11147447
[No Abstract] [Full Text] [Related]
13. [Disseminated intravascular coagulation].
Páramo JA
Med Clin (Barc); 2006 Nov; 127(20):785-9. PubMed ID: 17198666
[No Abstract] [Full Text] [Related]
14. [Current treatment concepts in heparin-induced thrombocytopenia].
Ranze O; Greinacher A
Dtsch Med Wochenschr; 1999 Jul; 124(28-29):865-73. PubMed ID: 10432950
[No Abstract] [Full Text] [Related]
15. [Successful therapy of heparin-associated thrombocytopenia with a low sulfated heparinoid].
Herzog S; Rath W; Kuhn W
Geburtshilfe Frauenheilkd; 1995 Mar; 55(3):164-6. PubMed ID: 7665065
[TBL] [Abstract][Full Text] [Related]
16. [Successful treatment with the combination of recombinant human soluble thrombomodulin and gabexate mesilate in three patients with obstetric disseminated intravascular coagulation].
Kumura T; Aoyama Y; Ichihara H; Koh S; Mugitani A; Hayakawa H; Yukioka K; Kinoshita D; Nakagawa M; Yamazaki N
Rinsho Ketsueki; 2011 Feb; 52(2):68-72. PubMed ID: 21403426
[TBL] [Abstract][Full Text] [Related]
17. [Delayed intracutaneous test reaction in heparin intolerance].
Wurpts G; Merk HF
Hautarzt; 2007 May; 58(5):394-6. PubMed ID: 17450341
[No Abstract] [Full Text] [Related]
18. [Treatment with recombinant thrombomodulin on disseminated intravascular coagulation caused by urinary tract infections; a retrospective comparative study with control cases].
Machioka K; Shigehara K; Kadomoto S; Iwamoto H; Miyagi T; Nakashima T; Namiki M
Hinyokika Kiyo; 2015 Jan; 61(1):1-6. PubMed ID: 25656012
[TBL] [Abstract][Full Text] [Related]
19. Recent Change in Treatment of Disseminated Intravascular Coagulation in Japan: An Epidemiological Study Based on a National Administrative Database.
Murata A; Okamoto K; Mayumi T; Muramatsu K; Matsuda S
Clin Appl Thromb Hemost; 2016 Jan; 22(1):21-7. PubMed ID: 25736054
[TBL] [Abstract][Full Text] [Related]
20. [Use of low molecular weight heparins by dermatologists].
Maakaroun A; Gruel Y
Ann Dermatol Venereol; 2003 Apr; 130(4):473-8. PubMed ID: 12843865
[No Abstract] [Full Text] [Related]
[Next] [New Search]
